Overview
ENTA market data
Price History
No market bars yet for ENTA. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ENTA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Enanta Pharmaceuticals Enters Open Market Sale Agreement With Jefferies; May Offer And Sell Up To $75M Of Common Stock Through JefferiesBenzinga · Jul 2, 2026, 9:05 PM
8-K filing — ENANTA PHARMACEUTICALS INC (ENTA)SEC EDGAR · Jul 2, 2026, 8:56 PM
'Pfizer Keeps Win in Patent Lawsuit Aimed at Paxlovid Antiviral' - BloombergBenzinga · Jun 23, 2026, 3:40 PM
HC Wainwright & Co. Reiterates Buy on Enanta Pharma, Maintains $20 Price TargetBenzinga · Jun 23, 2026, 11:40 AM
Enanta Pharma Advances Zelicapavir Into Registrational Phase 2b/3 Clinical Trial In Adults At High Risk Of Severe Outcomes From RSV Infection After End-Of-Phase 2 Meeting With FDABenzinga · Jun 18, 2026, 11:10 AM
Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga · May 28, 2026, 12:05 PM
European Medicines Agency Announces Meeting highlights From The Committee For Medicinal Products for Human Use, May 18-21Benzinga · May 22, 2026, 11:05 AM